Heparin    body {font-family: 'Open Sans', sans-serif;}

### Heparin and Neuraxial Block

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Heparin at doses: | Minimal Time between last  
dose and neuraxial procedure | Can it be given with  
epidural catheter in place? | Restart after neuraxial procedure  
and/or catheter insertion | When to restart after  
catheter removal |
| --- | --- | --- | --- | --- |
| Heparin  
(low dose, SQ)  
â‰¤ 5,000 units | 4-6 hours  
5,000 units SQ of unfractionated  
heparin will have significant anticoagulant  
effect for 4-6 hours | Avoid  
  
Other source: No restrictions | Immediately  
Avoid if indwelling  
catheter is in place  
  
Other source: No restrictions | Immediately |
| Heparin  
(high dose, SQ)  
5,000 - 10, 000 units  
QD or BID | 12 hours with normal  
coagulation status verified | ASRA: Unknown risk for doses > 5,000 units  
  
Other source: Avoid | ASRA: Unknown risk  
for doses > 5,000 units  
  
Other source: 4 hours in absence  
of indwelling catheter | Immediately |
| Heparin  
IV infusion | 4-6 hours if aPTT is normal or  
anti-Xa activity undetectable | Avoid | 4 hours  
Avoid with indwelling  
catheter in place | 1 hour after removal  
or 4 hours after procedure. |

  
**Deep plexus and peripheral blocks:** Avoid**Superficial peripheral blocks:** Based on vascularity, site compressibility and available management if bleeding occurred.  
  
**Labs:**  
aPTT and ACT  
Always refer to the latest ASRA (American Society of Regional Anesthesia and Pain) Recommendations  
https://www.asra.com/advisory-guidelines  
  
ASRA Assistance:  
Toll free in US: 855-795-ASRA (2772)  
412-471-2718  
asraassistant@asra.com  
  

Other source:  
MANAGEMENT OF ANTITHROMBOTIC THERAPY  
FOR NEURAXIAL AND PERIPHERAL NERVE PROCEDURES, 2018  
https://depts.washington.edu/anticoag/home/sites/default/files/Management%20of%20Antithrombotic%20Therapy%20for%20Neuraxial%20and%20Peripheral%20Nerve%20Procedures.pdf